Volume : IV, Issue : VI, June - 2014
A Non randomised controlled trial of Eprosartan
Dr. Kumari Doully, Dr. Dewesh Kumar, Dr. S. B Sinha
Abstract :
Isolated Systolic Hypertension is the most common form of hypertension in elderly which is a known risk factor for end organ damage. The aim of the present study was to study the role of Eprosartan in managing Isolated systolic hypertension (ISH) and its side effects. It was a Non randomised controlled trial conducted in Darbhanga Medical College & Hospital, Laheriasarai(Bihar) during March 2010 to December 2011. A total of 50 patients with experimental and control group was studied. The experimental group(20patients) with systolic blood pressure(SBP) less than 160 mmHg and the second experimental group(20patients) with systolic blood pressure more than 160 both showed significant decrease of SBP(p<0.001) whereas control group patients showed no significant difference after 2 &4 weeks. Eprosartan is quite effective in controlling ISH with secondary prevention of cereovascular and cardiovascular events. This can be used by physicians considering its excellent long term safety and efficacy
Keywords :
Article:
Download PDF
DOI : 10.36106/ijar
Cite This Article:
Dr. Kumari Doully, Dr. Dewesh Kumar, Dr. S. B Sinha A Non randomised controlled trial of Eprosartan Indian Journal of Applied Research, Vol.IV, Issue.VI June 2014
Number of Downloads : 1103
Dr. Kumari Doully, Dr. Dewesh Kumar, Dr. S. B Sinha A Non randomised controlled trial of Eprosartan Indian Journal of Applied Research, Vol.IV, Issue.VI June 2014
Our Other Journals...
-
International Journal of
Scientific Research Visit Website -
PARIPEX Indian Journal
of Research Visit Website -
Global Journal for
Research Analysis Visit Website